Emergent Health(EMGE)
$0.000.00 (0.00%)
EMGE
Emergent Health financials statements
$0.00
At close:0.00 (0.00%)
Emergent Health (EMGE) Ratios
9 Followers
Emergent Health Ratios
EMGE's free cash flow for Q3 2024 was $-56.47K. For the 2024 fiscal year, EMGE's free cash flow was increased by $0.00 and operating cash flow was $-56.47K. See a summary of the company’s cash flow.
| Ratios | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.14 | 0.34 | 0.94 | 0.00 | 83.39 |
| Quick Ratio | 0.14 | 0.34 | 0.94 | 0.00 | 83.39 |
| Cash Ratio | 0.01 | 0.01 | 0.74 | 0.00 | 60.49 |
| Solvency Ratio | -0.56 | -1.13 | -0.77 | 0.00 | -15.35 |
| Operating Cash Flow Ratio | -0.42 | -1.03 | -0.47 | 0.00 | -14.48 |
| Short-Term Operating Cash Flow Coverage | -0.49 | -1.14 | -0.48 | 0.00 | 0.00 |
| Net Current Asset Value | $ -2.49M | $ -1.22M | $ -19.87K | $ 249.98K | $ 308.72K |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 4.65 | 2.10 | 0.89 | 0.00 | 0.00 |
| Debt-to-Equity Ratio | -1.02 | -1.45 | -6.07 | 0.00 | 0.00 |
| Debt-to-Capital Ratio | 55.32 | 3.21 | 1.20 | 0.00 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 55.32 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | -0.22 | -0.69 | -6.81 | 1.38 | 1.30 |
| Debt Service Coverage Ratio | -0.51 | -0.85 | -0.42 | 0.00 | -4.96 |
| Interest Coverage Ratio | -6.40 | -4.86 | -2.21 | 0.00 | -5.98 |
| Debt to Market Cap | 17.60 | 1.59 | 0.10 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 |
| Net Debt to EBITDA | -1.77 | -0.95 | -0.44 | 3.03 | 4.65 |
| Profitability Margins | |||||
| Gross Profit Margin | 63.49% | 22.21% | 49.74% | 72.62% | 70.26% |
| EBIT Margin | -86.10% | -304.08% | -166.91% | -45.45% | -32.08% |
| EBITDA Margin | -84.88% | -300.60% | -150.18% | -33.48% | -26.62% |
| Operating Profit Margin | -86.10% | -305.61% | -166.91% | -47.69% | -32.08% |
| Pretax Profit Margin | -99.57% | -367.00% | -242.41% | -47.69% | -37.44% |
| Net Profit Margin | -99.57% | -366.76% | -241.51% | -47.33% | -36.86% |
| Continuous Operations Profit Margin | -99.57% | -367.00% | -242.41% | -47.69% | -37.44% |
| Net Income Per EBT | 100.01% | 99.93% | 99.63% | 99.23% | 98.44% |
| EBT Per EBIT | 115.64% | 120.09% | 145.24% | 100.00% | 116.73% |
| Return on Assets (ROA) | -305.05% | -266.69% | -76.22% | -24.61% | -16.71% |
| Return on Equity (ROE) | 66.78% | 184.08% | 519.34% | -33.94% | -21.68% |
| Return on Capital Employed (ROCE) | 59.85% | 165.76% | -630.97% | -24.80% | -14.68% |
| Return on Invested Capital (ROIC) | -1079.22% | -291.45% | -54.04% | -24.80% | -14.68% |
| Return on Tangible Assets | -363.70% | -308.04% | -87.80% | -31.46% | -16.71% |
| Earnings Yield | -577.17% | -201.98% | -8.88% | -1.92% | -1.33% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 2.30 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 2.37 | 2.44 | 6.27 | 0.00 | 0.00 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 32.70 | 11.49 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 3.06 | 0.73 | 0.32 | 0.52 | 0.45 |
| Working Capital Turnover Ratio | -0.88 | -0.93 | 1.04 | 0.60 | 0.00 |
| Cash Conversion Cycle | -153.83 | 8.94 | -58.19 | 0.00 | 0.00 |
| Days of Sales Outstanding | 0.00 | 158.80 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 153.83 | 149.86 | 58.19 | 0.00 | 0.00 |
| Operating Cycle | 0.00 | 158.80 | 0.00 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.00 | -0.01 | -0.00 | -0.00 | -0.00 |
| Free Cash Flow Per Share | -0.00 | -0.01 | -0.00 | -0.00 | -0.00 |
| Dividend Paid and CapEx Coverage Ratio | 0.00 | -37.92 | 0.00 | 0.00 | 0.00 |
| Capital Expenditure Coverage Ratio | 0.00 | -37.92 | 0.00 | 0.00 | 0.00 |
| Operating Cash Flow Coverage Ratio | -0.49 | -1.14 | -0.48 | 0.00 | 0.00 |
| Operating Cash Flow to Sales Ratio | -0.75 | -3.30 | -1.35 | -0.34 | -0.30 |
| Free Cash Flow Yield | -432.43% | -186.51% | -4.97% | -1.39% | -1.07% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.17 | -0.50 | -11.27 | -52.16 | -75.28 |
| Price-to-Sales (P/S) Ratio | 0.17 | 1.82 | 27.21 | 24.69 | 27.75 |
| Price-to-Book (P/B) Ratio | -0.12 | -0.91 | -58.52 | 17.70 | 16.32 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -0.23 | -0.54 | -20.13 | -72.09 | -93.68 |
| Price-to-Operating Cash Flow Ratio | -0.23 | -0.55 | -20.13 | -72.09 | -93.68 |
| Price-to-Earnings Growth (PEG) Ratio | 0.00 | -0.01 | -0.04 | -3.13 | 0.00 |
| Enterprise Value Multiple | -1.97 | -1.56 | -18.56 | -70.70 | -99.60 |
| Enterprise Value | 2.74M | 2.69M | 3.33M | 3.96M | 4.85M |
| EV to EBITDA | -1.97 | -1.56 | -18.56 | -70.70 | -99.60 |
| EV to Sales | 1.68 | 4.68 | 27.88 | 23.67 | 26.51 |
| EV to Free Cash Flow | -2.25 | -1.38 | -20.62 | -69.14 | -89.50 |
| EV to Operating Cash Flow | -2.25 | -1.42 | -20.62 | -69.14 | -89.50 |
| Tangible Book Value Per Share | -0.01 | -0.00 | -0.00 | 0.00 | 0.01 |
| Shareholders’ Equity Per Share | -0.01 | -0.00 | -0.00 | 0.00 | 0.01 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -0.00 | -0.01 | -0.00 | -0.00 | -0.00 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 0.99 | 0.98 |
| Interest Burden | 1.16 | 1.21 | 1.45 | 1.05 | 1.17 |
| Research & Development to Revenue | 0.02 | 0.01 | 0.02 | 0.01 | 0.05 |
| SG&A to Revenue | 0.00 | 0.00 | 1.30 | 0.28 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.75 | 0.90 | 0.56 | 0.72 | 0.80 |
Currency in USD

